For the year ending 2025-12-31, SGMT has $116,482K in assets. $35,021K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 35,021 | |||
| Short-term marketable securities | 78,103 | |||
| Prepaid expenses and other current assets | 3,280 | |||
| Total current assets | 116,404 | |||
| Long-term marketable securities | 0 | |||
| Operating lease right-of-use assets | 78 | |||
| Total assets | 116,482 | |||
| Accounts payable | 1,309 | |||
| Accrued expenses and other current liabilities | 3,714 | |||
| Operating lease liabilities | 78 | |||
| Total current liabilities | 5,101 | |||
| Common stock-Common Class A | 3 | |||
| Common stock-Common Class B | 0 | |||
| Additional paid-in capital | 457,607 | |||
| Accumulated deficit | -346,349 | |||
| Accumulated other comprehensive income | 120 | |||
| Total stockholders' equity | 111,381 | |||
| Total liabilities and stockholders' equity | 116,482 | |||
Sagimet Biosciences Inc. (SGMT)
Sagimet Biosciences Inc. (SGMT)